✦ LIBER ✦

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults

✍ Scribed by Sharon Frey; Gregory Poland; Sandra Percell; Audino Podda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of MF59-adjuva

✍ S De Donato; D Granoff; M Minutello; G Lecchi; M Faccini; M Agnello; F Senatore; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Safety and immunogenicity of an MF59®-ad

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Immunogenicity, safety and tolerability

✍ Laura Dell’Era; Fabrizia Corona; Cristina Daleno; Alessia Scala; Nicola Principi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Increased immunogenicity of the MF59-adj

✍ R. Gasparini; T. pozzi; E. Montomoli; E. Fragapane; F. Senatore; M. Minutello; A 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 82 KB

MF59®-adjuvanted influenza vaccine (FLUA

✍ T. Vesikari; N. Groth; A. Karvonen; A. Borkowski; M. Pellegrini 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 198 KB

The virosomal influenza vaccine Invivac®

✍ I.A. de Bruijn; J. Nauta; L. Gerez; A.M. Palache 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 83 KB